Patents by Inventor Robin Andrew Smith

Robin Andrew Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
    Patent number: 6215002
    Abstract: There are described according to the invention, processes for making compounds of formula (XXVIII)3 (relative stereochemistry indicated), wherein P2 is as defined in the specification.
    Type: Grant
    Filed: March 3, 2000
    Date of Patent: April 10, 2001
    Assignee: Glaxo Wellcome Inc.
    Inventors: Michael Dennis Dowle, Harry Finch, Lee Andrew Harrison, Graham George Inglis, Martin Redpath Johnson, Simon John Fawcett MacDonald, Pritom Shah, Robin Andrew Smith
  • Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
    Patent number: 5994344
    Abstract: There are described according to the invention compounds of formula (I) (relative stereochemistry indicated), wherein R.sub.1, R.sub.2, R.sub.3 and X are as defined in the specification, together with processes for preparing them, compositions containing them and their use as pharmaceuticals. Compounds of formula (I) are indicated inter alia for the treatment of chronic bronchitis.
    Type: Grant
    Filed: September 25, 1998
    Date of Patent: November 30, 1999
    Assignee: Glaxo Wellcome Inc.
    Inventors: Michael Dennis Dowle, Harry Finch, Lee Andrew Harrison, Graham George Inglis, Martin Redpath Johnson, Simon John Fawcett Macdonald, Pritom Shah, Robin Andrew Smith